Further experiments with pancreatic cancer cell lines treated with shRNA showed that SLC6A14 knock-down decreased the invasion of cancer cells, as measured in the transwell assay (Cheng et al., 2019). This evidence concerns the gene SLC6A14 and pancreatic neoplasm.